Parenteral anticoagulants in heart disease: Current status and perspectives (Section II) Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease

Parenteral anticoagulants in heart disease : Current status and perspectives (Section II) Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease

De Caterina, Raffaele (author)

Husted, Steen (author)

Wallentin, Lars (author): Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi,Science for Life Laboratory, SciLifeLab

Andreotti, Felicita (author)

Arnesen, Harald (author)

Bachmann, Fedor (author)

Baigent, Colin (author)

Huber, Kurt (author)

Jespersen, Jorgen (author)

Kristensen, Steen Dalby (author)

Lip, Gregory Y. H. (author)

Morais, Joao (author)

Rasmussen, Lars Hvilsted (author)

Siegbahn, Agneta (author): Uppsala universitet,Koagulation och inflammationsvetenskap

Verheugt, Freek W. A. (author)

Weitz, Jeffrey I. (author)

(creator_code:org_t)

2013
2013
English.
In: Thrombosis and Haemostasis. - 0340-6245 .- 2567-689X. ; 109:5, s. 769-786

Related links:: https://urn.kb.se/re...; show more...; https://doi.org/10.1...; show less...

Abstract Subject headings

Anticoagulants are a mainstay of cardiovascular therapy, and parenteral anticoagulants have widespread use in cardiology, especially in acute situations. Parenteral anticoagulants include unfractionated heparin, low-molecular-weight heparins, the synthetic pentasaccharides fondaparinux, idraparinux and idrabiotaparinux, and parenteral direct thrombin inhibitors. The several shortcomings of unfractionated heparin and of low-molecular-weight heparins have prompted the development of the other newer agents. Here we review the mechanisms of action, pharmacological properties and side effects of parenteral anticoagulants used in the management of coronary heart disease treated with or without percutaneous coronary interventions, cardioversion for atrial fibrillation, and prosthetic heart valves and valve repair. Using an evidence-based approach, we describe the results of completed clinical trials, highlight ongoing research with currently available agents, and recommend therapeutic options for specific heart diseases.

By the author/editor: De Caterina, Raf ...; Husted, Steen; Wallentin, Lars; Andreotti, Felic ...; Arnesen, Harald; Bachmann, Fedor; show more...; Baigent, Colin; Huber, Kurt; Jespersen, Jorge ...; Kristensen, Stee ...; Lip, Gregory Y. ...; Morais, Joao; Rasmussen, Lars ...; Siegbahn, Agneta; Verheugt, Freek ...; Weitz, Jeffrey I ...; show less...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.